41 research outputs found

    Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis

    Get PDF
    Background: Cardiac involvement is common in amyloidosis and associated with a variably adverse outcome. We have previously shown that cardiovascular magnetic resonance (CMR) can assess deposition of amyloid protein in the myocardial interstitium. In this study we assessed the prognostic value of late gadolinium enhancement (LGE) and gadolinium kinetics in cardiac amyloidosis in a prospective longitudinal study.Materials and methods: The pre-defined study end point was all-cause mortality. We prospectively followed a cohort of 29 patients with proven cardiac amyloidosis. All patients underwent biopsy, 2D-echocardiography and Doppler studies, I-123-SAP scintigraphy, serum NT pro BNP assay, and CMR with a T-1 mapping method and late gadolinium enhancement (LGE).Results: Patients with were followed for a median of 623 days (IQ range 221, 1436), during which 17 (58%) patients died. The presence of myocardial LGE by itself was not a significant predictor of mortality. However, death was predicted by gadolinium kinetics, with the 2 minute post-gadolinium intramyocardial T1 difference between subepicardium and subendocardium predicting mortality with 85% accuracy at a threshold value of 23 ms (the lower the difference the worse the prognosis). Intramyocardial T1 gradient was a better predictor of survival than FLC response to chemotherapy (Kaplan Meier analysis P = 0.049) or diastolic function (Kaplan-Meier analysis P = 0.205).Conclusion: In cardiac amyloidosis, CMR provides unique information relating to risk of mortality based on gadolinium kinetics which reflects the severity of the cardiac amyloid burden

    Automatic left ventricle volume calculation with explainability through a deep learning weak-supervision methodology

    Full text link
    [EN] Background and objective: Magnetic resonance imaging is the most reliable imaging technique to assess the heart. More specifically there is great importance in the analysis of the left ventricle, as the main pathologies directly affect this region. In order to characterize the left ventricle, it is necessary to extract its volume. In this work we present a neural network architecture that is capable of directly estimating the left ventricle volume in short axis cine Magnetic Resonance Imaging in the end-diastolic frame and provide a segmentation of the region which is the basis of the volume calculation, thus offering explain-ability to the estimated value. Methods: The network was designed to directly target the volumes to estimate, not requiring any labeled segmentation on the images. The network was based on a 3D U-net with extra layers defined in a scan-ning module that learned features like the circularity of the objects and the volumes to estimate in a weakly-supervised manner. The only targets defined were the left ventricle volumes and the circularity of the object detected through the estimation of the pi value derived from its shape. We had access to 397 cases corresponding to 397 different subjects. We randomly selected 98 cases to use as test set. Results: The results show a good match between the real and estimated volumes in the test set, with a mean relative error of 8% and a mean absolute error of 9.12 ml with a Pearson correlation coefficient of 0.95. The derived segmentations obtained by the network achieved Dice coefficients with a mean value of 0.79. Conclusions: The proposed method is capable of obtaining the left ventricle volume biomarker in the end-diastole and offer an explanation of how it obtains the result in the form of a segmentation mask without the need of segmentation labels to train the algorithm, making it a potentially more trustworthy method for clinicians and a way to train neural networks more easily when segmentation labels are not readily available.The authors acknowledge financial support from the Consel-leria d'Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana (grants AEST/2019/037 and AEST/2020/029) , from the Agencia Valenciana de la Innovacion, Generalitat Valenciana (ref. INNCAD00/19/085) , and from the Centro para el Desarrollo Tecnologico Industrial (Programa Eurostars2, actuacion Interempresas Internacional) , Spanish Ministerio de Ciencia, Innovacion y Universidades (ref. CIIP-20192020) .Pérez-Pelegrí, M.; Monmeneu, JV.; López-Lereu, MP.; Pérez-Pelegrí, L.; Maceira, AM.; Bodi, V.; Moratal, D. (2021). Automatic left ventricle volume calculation with explainability through a deep learning weak-supervision methodology. Computer Methods and Programs in Biomedicine. 208:1-8. https://doi.org/10.1016/j.cmpb.2021.106275S1820

    Modificaciones de la función ventricular izquierda con dosis crecientes de dobutamina en individuos sanos

    Get PDF
    E1 objetivo fue valorar los cambios de la función ventricular con dosis crecientes de dobutamina en jóvenes sanos. Se realizó ventriculografía isotópica en situación basal, con dosis baja (10 µg/Kg/min) y alta (40 µg/Kg/min) del fármaco. Se estudiaron la fracción de eyección global, segmentaria y del primer tercio de la sístole, la velocidad máxima de llenado diastólico y el tiempo hasta la velocidad máxima de llenado. Se observó un aumento progresivo de la fracción de eyección global con las dosis sucesivas del fármaco. La fracción de eyección segmentaria, fracción de eyección del primer tercio de la sístole y la velocidad máxima de llenado aumentaron con la dosis baja sin mostrar diferencias con la alta. Se concluye que la dobutamina en jóvenes sanos y en estas dosis induce un aumento significativo de todos los parámetros sistólicos y de la velocidad máxima de llenado, sin modificar el tiempo hasta la velocidad máxima de llenado
    corecore